Art

J-GLOBAL ID：201802244534853083   Reference number：18A0120426

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome

ステロイド耐性ネフローゼ症候群を伴う特発性膜性腎症に関するステロイド併用ミゾリビン療法およびミゾリビン血液濃度モニタリング

Author (19)： SAITO Takao (Fukuoka Univ., Fukuoka, JPN) ,  IWANO Masayuki (Univ. Fukui, Fukui, JPN) ,  MATSUMOTO Koichi (Nihon Univ., Tokyo, JPN) ,  MITARAI Tetsuya (Saitama Medical Univ., Kawagoe, JPN) ,  YOKOYAMA Hitoshi (Kanazawa Medical Univ. School of Medicine. Ishikawa, JPN) ,  YORIOKA Noriaki (Hiroshima Kidney Organization, Hiroshima, JPN) ,  NISHI Shinichi (Kobe Univ. Graduate School of Medicine, Kobe, JPN) ,  YOSHIMURA Ashio (Showa Univ. Fujigaoka Hospital, Yokohama, JPN) ,  SATO Hiroshi (Tohoku Univ. Graduate School of Medicine, Sendai, JPN) ,  OGAHARA Satoru (Fukuoka Univ., Fukuoka, JPN) ,  SASATOMI Yoshie (Fukuoka Univ., Fukuoka, JPN) ,  KATAOKA Yasufumi (Fukuoka Univ., Fukuoka, JPN) ,  UEDA Shiro (Ueda Clinic, Chiba, JPN) ,  KOYAMA Akio ,  MARUYAMA Shoichi (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  NANGAKU Masaomi (Univ. Tokyo School of Medicine, Tokyo, JPN) ,  IMAI Enyu (Nakayamadera Imai Clinic, Hyogo, JPN) ,  MATSUO Seiichi (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  TOMINO Yasuhiko
Material： Clinical and Experimental Nephrology  (Clin Exp Nephrol)
Volume： 21  Issue： 6  Page： 961-970  Publication year： Dec. 2017 
JST Material Number： L3173A  ISSN： 1342-1751  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： steroid resistant nephrotic syndrome ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0120426&from=J-GLOBAL&jstjournalNo=L3173A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O)

Substance index (2)： Mizoribine ,  Prednisolone

Reference (33)：

• Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400-7.
• Cattran DC, Feehally J, Cook HT, et al. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:S139-274.
• Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007;72:1429-47.
• Yoshioka K, Ohashi Y, Sakai T, Ito H, Yoshikawa N, Nakamura H, et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int. 2000;58:317-24.
• Shibasaki T, Koyama A, Hishida A, Muso E, Osawa G, Yamabe H, et al. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). Clin Exp Nephrol. 2004;8:117-26.

Terms in the title (8)： ステロイド耐性ネフローゼ症候群 ,  特発性膜性腎症 ,  ステロイド ,  併用 ,  ミゾリビン ,  療法 ,  血液 ,  モニタリング